Letairis Copay Assistance Program

Letairis (ambrisentan) is a prescription medicine to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of your lungs. LETAIRIS can improve your ability to exercise and it can help slow down the worsening of your physical condition and symptoms.
For those taking LETAIRIS there are a few options if you can’t afford your prescription:

1. Co-PaySolutions can help reduce the cost of treatment for people who have private insurance. This program works to limit your out-of-pocket expenses to $25 per month. If you are eligible for this program, Gilead may be able to provide you with assistance up to a maximum benefit of $9,200 per year.
2. FoundationSolutions can help people with Medicare or other government-funded insurance find financial and reimbursement support for many out-of-pocket costs. For individuals with private insurance, FoundationSolutions may be able to help pay for monthly premiums, deductibles, and co-payments.
3. If you currently lack insurance coverage and are not able to pay for medications, PatientAssistanceSolutions may be able to help you find coverage and financial support through public insurance programs. PatientAssistanceSolutions can also help individuals who do not qualify for public insurance find programs that can offer LETAIRIS free of charge.

LETAIRIS is a prescription medicine to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of your lungs.

LETAIRIS can improve your ability to exercise (as measured by how far you can walk in 6 minutes) and it can help slow down the worsening of your physical condition and symptoms. In LETAIRIS clinical studies, clinical worsening was defined as any of the following: a need to go to the hospital for worsening PAH symptoms, a need to take additional PAH treatments, discontinuation of treatment due to worsening PAH symptoms, lung transplantation or other surgical procedures to reduce pulmonary pressures, or death.